COVID-19 Update As Of March 12: From Hundreds Of Thousands Of Specimens, Found 14,900 Positive Cases

Illustration of an examination of a COVID-19 case. (Photo: Pexels/@Polina Tankilevitch)

JAKARTA - The Ministry of Health (Kemenkes) released the latest additional positive cases of COVID-19 as of Saturday, March 12. A total of 211,102 specimens were examined with the result that 14,900 new positive cases of COVID-19 were found.

"The total accumulation of positive cases since COVID-19 was discovered in Indonesia has reached 5,878,910 people and active cases have decreased by 19,081 to 357,380 cases," said Ministry of Health data, Saturday, March 12.

Today's recovered cases increased by 33,733 cases, bringing the total to 5,369,579 recovered people. Then, there were 248 positive confirmed cases and a total of 151,951 people.

Still with the same data, the province with the highest new cases was recorded in West Java with 3 312 cases. Then, DKI Jakarta with 2,105 cases.

Central Java also recorded a significant addition of positive numbers with 1,275 cases. Then, East Java with 1165 cases.

Meanwhile, the province with the most recovered cases today is West Java with 10,066 cases. Then, DKI Jakarta with 4,100 cases.

Then, Central Java was also recorded with quite high recovered cases, namely, 2,344 cases. Lalau, East Java with 2324 cases recovered.

In addition, the number of specimens that have been examined using RT-PCR, TCM, and antigens reached 88,910,570

"Positive results per number of people examined or the positivity rate of people this week is 15.2 percent," he wrote.

The number of people suspected of contracting COVID-19 or currently categorized as suspected cases is 14,812 people. Currently, 34 provinces have had cases of COVID-19.

So far, 193,229,487 people have received the first dose of COVID-19 vaccination and 150,773,781 people have received the second dose of vaccination.

While the third dose of vaccination was 14,03,132. Meanwhile, the target for vaccination in Indonesia is 208,351,546 people.